Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn

Autoflex III Mass Spectrometer
Aug 2006
Bruker Daltonics Inc.Request Info
PRAGUE, Czech Republic, Aug. 28, 2006 -- Bruker Daltonics introduced its new autoflex III smartbeam vertical MALDI-TOF (matrix-assisted laser desorption-ionization/time-of-flight), or TOF/TOF, mass spectrometer at the 17th International Mass Spectrometry Conference, being held this week in Prague. Bruker said that mass resolution, accuracy, sensitivity, analytical versatility and reliability have been enhanced in the new autoflex III smartbeam instruments for optimum performance in expression proteomics and quantitative proteomics, as well as in peptide/protein biomarker discovery, identification and validation.

autoflex.jpgBased on Bruker Daltonics' smartbeam laser technology, the novel autoflex III series is particularly suited for MALDI molecular imaging applications in in-vitro imaging of peptide and protein biomarker distributions in tissue sections, e.g., in tumor regions. The smartbeam laser allows variable repetition rates from 1 Hz up to 200 Hz, with a computer-controlled, adjustable laser focus size and unrivaled spatial resolution, Bruker said.

In addition to a fourfold sensitivity increase compared to the autoflex II, the latest autoflex III offers major advances in mass resolution over a broad mass range, using panoramic PAN technology -- the same technology used in Bruker Daltonics' top-of-the-line ultraflex TOF/TOF series. Mass spectra with the simultaneous highest resolution over an extended mass range greatly increase success rates in protein database identifications, without the need to optimize instrument parameters.

Bruker Daltonics said with LIFT TOF/TOF ion optics and unique smartbeam technology for unprecedented analytical versatility in sample types, matrices, etc., the autoflex III and ultimate-performance ultraflex III are the preferred MALDI systems for quantitative expression proteomics, top-down proteomics, intact protein analysis, LC-MALDI workflows and clinical proteomics.

The new autoflex III is fully integrated into Bruker Daltonics solution packages such as its ClinProt for biomarker discovery, MALDI molecular imager for biomarker distribution in tissue section, its Proteineer line (the 2-D gel-based proteomics suite) and its Proteineer LC line (the LC-based proteomics suite).

Michael Schubert, executive vice president of Bruker Daltonics, said, "We have now implemented many of the cutting-edge technologies from our top-of-the-line ultraflex MALDI-TOF/TOF, like smartbeam laser, PAN resolution over a broad mass range and 4X sensitivity enhancements, into our compact vertical autoflex III system to perform at the highest level. Moreover, statistical biomarker data obtained with the autoflex III can now be merged easily with molecular images for in-depth investigation of the spatial distribution of peptides and proteins in tissues."

For more information, visit: or; e-mail:

Bruker Daltonics Inc.
40 Manning Rd.
Manning Park
Billerica, MA 01821
Phone: (978) 663-3660
Fax: (978) 667-5993


* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address 2:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required
autoflex IIIBruker Daltonicsexpression proteomicsindustrialInternational Mass Spectrometry ConferenceMaldi-Tofmass spectrometerpeptide/protein biomarkerProductsquantitative proteomicssmartbeamspectroscopyTOF/TOF

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
Are you interested in this product?
If you'd like Bruker Daltonics Inc. to reach out to you with more information about this product, please supply your email and they will contact you.

Email Address:
Stop showing me this for the remainder of my visit